28 November 2025
28 November 2025
In the Clinical Research category, the award went to Rita Fior, leader of the Cancer Development and Innate Immune Evasion Group, for the study “The zAvatar test forecasts clinical treatment response in patients with colorectal cancer: a co-clinical study paving the way for personalised medicine.” Bruna Costa, a postdoctoral researcher, is the first author of the recognised work.
On March 13, 2026, the Champalimaud Foundation will host the Lung Cancer Fight Club – 3rd Round, a multidisciplinary meeting bringing together renowned scientists and clinicians to discuss cutting-edge strategies in lung cancer management.
This year’s symposium will provide a platform for knowledge exchange across surgery, radiotherapy, interventional pulmonology, genetics, nutrition, physical activity, mental health, and applied technologies in oncology.
25 November 2025
When Tiago Santos first walked through the glass corridors of the Champalimaud Foundation (CF) in 2014, he already had two years of nursing experience, but none in urology or oncology. “Deep down, one could say I started a new chapter of my career here,” he admits with a wry smile. Indeed, stepping into a nearly empty unit with no reference guides, protocols, or precedents might have made most people run for the hills. But not Tiago. For him, the emptiness was an invitation: a white canvas on which to paint the future of urology nursing at CF.
24 November 2025
The work fits into a broader effort to understand how the immune system maintains balance – a theme underscored by this year’s Nobel Prize in Physiology or Medicine for discoveries in immune tolerance.
21 Nov. 2025
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a MRI Technician to join our team at the Champalimaud Research Program.
20 November 2025
When I interviewed Albino J. Oliveira-Maia, we spoke about the challenges and lessons that shaped his career. What struck me most was his ability to pursue different things at once and to create the space to keep doing so. By writing this, I hope to share that feeling of courage with others who are now wondering which path to follow.
20 November 2025
When Marta Moita first heard whispers of a neuroscience programme taking shape in Lisbon, disbelief was her first reaction. “It just didn’t seem possible,” she recalls. She was a young Principal Investigator (PI) who had returned to Portugal after years abroad, because behavioural neuroscience (her passion) simply didn’t exist here. “So the prospect of not just having a lab, but a whole programme doing circuits and behavioral neuroscience in Lisbon, with people I knew and admired… it was just difficult to assimilate. Was this really happening?”